Literature DB >> 21104301

Inorganic nanoparticles in cancer therapy.

Sanjib Bhattacharyya1, Rachel A Kudgus, Resham Bhattacharya, Priyabrata Mukherjee.   

Abstract

Nanotechnology is an evolving field with enormous potential for biomedical applications. The growing interest to use inorganic nanoparticles in medicine is due to the unique size- and shape-dependent optoelectronic properties. Herein, we will focus on gold, silver and platinum nanoparticles, discussing recent developments for therapeutic applications with regard to cancer in terms of nanoparticles being used as a delivery vehicle as well as therapeutic agents. We will also discuss some of the key challenges to be addressed in future studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104301      PMCID: PMC3072278          DOI: 10.1007/s11095-010-0318-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  176 in total

Review 1.  Quantum dots as cellular probes.

Authors:  A Paul Alivisatos; Weiwei Gu; Carolyn Larabell
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

Review 2.  Mechanisms of protein assembly: lessons from minimalist models.

Authors:  Yaakov Levy; José N Onuchic
Journal:  Acc Chem Res       Date:  2006-02       Impact factor: 22.384

3.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

4.  Radioisotopes in treatment of stage Ia ovarian cancer.

Authors:  H J Buchsbaum; W C Keettel
Journal:  Natl Cancer Inst Monogr       Date:  1975-10

Review 5.  Towards new transition metal-based hypoxic selective agents for therapy and imaging.

Authors:  P J Blower; J R Dilworth; R I Maurer; G D Mullen; C A Reynolds; Y Zheng
Journal:  J Inorg Biochem       Date:  2001-05       Impact factor: 4.155

6.  Antiangiogenic properties of gold nanoparticles.

Authors:  Priyabrata Mukherjee; Resham Bhattacharya; Ping Wang; Ling Wang; Sujit Basu; Janice A Nagy; Anthony Atala; Debabrata Mukhopadhyay; Shay Soker
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

7.  pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery.

Authors:  Savita Bisht; Gajadhar Bhakta; Susmita Mitra; Amarnath Maitra
Journal:  Int J Pharm       Date:  2004-11-21       Impact factor: 5.875

8.  High-efficiency gene delivery for expression in mammalian cells by nanoprecipitates of Ca-Mg phosphate.

Authors:  E H Chowdhury; Megumi Kunou; Masato Nagaoka; A K Kundu; Takashi Hoshiba; Toshihiro Akaike
Journal:  Gene       Date:  2004-10-27       Impact factor: 3.688

9.  Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium.

Authors:  T Maruo; M Yamasaki; C A Ladines-Llave; M Mochizuki
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

10.  Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.

Authors:  Jun-Jie Yin; Fang Lao; Jie Meng; Peter P Fu; Yuliang Zhao; Gengmei Xing; Xueyun Gao; Baoyun Sun; Paul C Wang; Chunying Chen; Xing-Jie Liang
Journal:  Mol Pharmacol       Date:  2008-07-17       Impact factor: 4.436

View more
  55 in total

Review 1.  Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors:  Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

2.  Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence.

Authors:  Sana Iram; Manaal Zahera; Iram Wahid; Abu Baker; Mohammad Raish; Altaf Khan; Naushad Ali; Saheem Ahmad; Mohd Sajid Khan
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

Review 3.  Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Authors:  Rochelle R Arvizo; Sanjib Bhattacharyya; Rachel A Kudgus; Karuna Giri; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 4.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

5.  Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.

Authors:  Jamey P Weichert; Paul A Clark; Irawati K Kandela; Abram M Vaccaro; William Clarke; Marc A Longino; Anatoly N Pinchuk; Mohammed Farhoud; Kyle I Swanson; John M Floberg; Joseph Grudzinski; Benjamin Titz; Anne M Traynor; Hong-En Chen; Lance T Hall; Christopher J Pazoles; Perry J Pickhardt; John S Kuo
Journal:  Sci Transl Med       Date:  2014-06-11       Impact factor: 17.956

6.  Findings on the interaction of the antimicrobial peptide cecropin-melittin with a gold surface from molecular dynamics studies.

Authors:  André F Ferreira; Akhilesh Rai; Lino Ferreira; Pedro N Simões
Journal:  Eur Biophys J       Date:  2016-07-28       Impact factor: 1.733

Review 7.  Redox-active nanomaterials for nanomedicine applications.

Authors:  Christopher M Sims; Shannon K Hanna; Daniel A Heller; Christopher P Horoszko; Monique E Johnson; Antonio R Montoro Bustos; Vytas Reipa; Kathryn R Riley; Bryant C Nelson
Journal:  Nanoscale       Date:  2017-10-19       Impact factor: 7.790

Review 8.  Serum protein adsorption and excretion pathways of metal nanoparticles.

Authors:  Rodrigo D Vinluan; Jie Zheng
Journal:  Nanomedicine (Lond)       Date:  2015-09-10       Impact factor: 5.307

9.  Polyamidoamine dendrimer liposome-mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis.

Authors:  Shuai Han; Zhai Cai; Liang Peng; Zhou Li; Hua-Bin Zhou; Xiu-Qin Li; Su-Zhen Fang; Zong-Hai Huang; Da-Xiang Cui
Journal:  Tumour Biol       Date:  2014-02-03

Review 10.  Inorganic nanosystems for therapeutic delivery: status and prospects.

Authors:  Chang Soo Kim; Gülen Yesilbag Tonga; David Solfiell; Vincent M Rotello
Journal:  Adv Drug Deliv Rev       Date:  2012-09-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.